OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
000210$59900.0059

DL Holdings Co Ltd

Commodity ChemicalsVerified

DL Holdings maintains a capital structure with a debt-to-equity ratio of 1.39, indicating a moderate reliance on debt financing. The company's liquidity position is characterized by a current ratio of 1.21, suggesting it can cover its short-term obligations but with limited buffer. Cash and equivalents amount to 1,102,665,161,500 KRW, while long-term debt stands at 5,589,170,499,860 KRW, resulting in a net cash position that is negative after subtracting total debt. Profitability metrics for DL Holdings show a return on equity (ROE) of -2.19% and a return on assets (ROA) of -0.72%, both of which are below the typical thresholds for healthy performance in the commodity chemicals industry. The company reported a net loss of 88,007,769,790 KRW, which contrasts with a gross profit of 1,126,332,936,400 KRW, indicating significant operating and non-operating expenses. Geographically, DL Holdings' revenue is concentrated in South Korea, with no disclosed international segments. The company's exposure to domestic market conditions is high, and its revenue concentration in a single region increases vulnerability to local economic and regulatory shifts. Looking ahead, DL Holdings is projected to experience a revenue decline in the current fiscal year, with a negative outlook for net income. The company's operating cash flow of 514,913,486,080 KRW and free cash flow of 120,462,848,530 KRW suggest some capacity to fund operations and investments, but capital expenditures of -241,600,404,490 KRW indicate ongoing investment in infrastructure and expansion. Risk factors for DL Holdings include liquidity concerns due to the negative net cash position and the potential for dilution, although the risk of dilution is currently assessed as low. The company's financial leverage and negative ROE highlight the need for careful monitoring of cost management and debt servicing. Recent events and disclosures for DL Holdings include analyst estimates that suggest a mean price target of 82,000 KRW, with a median of 82,000 KRW and a range from 81,000 KRW to 83,000 KRW. Analyst recommendations are mixed, with one strong buy, two buys, and no holds, indicating a generally positive but cautious outlook from the investment community.

30-day price · 000210(missing data)
No daily-bar history available from current data sources. Alternate source pending.
Profile
CompanyDL Holdings Co Ltd
Ticker000210.KS
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. DL Holdings Co Ltd is a South Korean company engaged in the production and sale of commodity chemicals, primarily serving the petrochemical and industrial sectors.

Classification. DL Holdings is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry, with a confidence level of 0.92 based on verified market data.

DL Holdings maintains a capital structure with a debt-to-equity ratio of 1.39, indicating a moderate reliance on debt financing. The company's liquidity position is characterized by a current ratio of 1.21, suggesting it can cover its short-term obligations but with limited buffer. Cash and equivalents amount to 1,102,665,161,500 KRW, while long-term debt stands at 5,589,170,499,860 KRW, resulting in a net cash position that is negative after subtracting total debt. Profitability metrics for DL Holdings show a return on equity (ROE) of -2.19% and a return on assets (ROA) of -0.72%, both of which are below the typical thresholds for healthy performance in the commodity chemicals industry. The company reported a net loss of 88,007,769,790 KRW, which contrasts with a gross profit of 1,126,332,936,400 KRW, indicating significant operating and non-operating expenses. Geographically, DL Holdings' revenue is concentrated in South Korea, with no disclosed international segments. The company's exposure to domestic market conditions is high, and its revenue concentration in a single region increases vulnerability to local economic and regulatory shifts. Looking ahead, DL Holdings is projected to experience a revenue decline in the current fiscal year, with a negative outlook for net income. The company's operating cash flow of 514,913,486,080 KRW and free cash flow of 120,462,848,530 KRW suggest some capacity to fund operations and investments, but capital expenditures of -241,600,404,490 KRW indicate ongoing investment in infrastructure and expansion. Risk factors for DL Holdings include liquidity concerns due to the negative net cash position and the potential for dilution, although the risk of dilution is currently assessed as low. The company's financial leverage and negative ROE highlight the need for careful monitoring of cost management and debt servicing. Recent events and disclosures for DL Holdings include analyst estimates that suggest a mean price target of 82,000 KRW, with a median of 82,000 KRW and a range from 81,000 KRW to 83,000 KRW. Analyst recommendations are mixed, with one strong buy, two buys, and no holds, indicating a generally positive but cautious outlook from the investment community.
Key takeaways
  • DL Holdings has a negative net income and ROE, indicating poor profitability.
  • The company's liquidity position is moderate, with a current ratio of 1.21.
  • DL Holdings is heavily leveraged, with a debt-to-equity ratio of 1.39.
  • Revenue is concentrated in South Korea, increasing exposure to local market risks.
  • Analysts have a generally positive outlook, with a mean price target of 82,000 KRW.
  • The company's capital expenditures suggest ongoing investment in infrastructure.
  • --
  • # RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyKRW
Revenue$5.33T
Gross profit$1.13T
Operating income$190.47B
Net income-$88.01B
R&D
SG&A
D&A
SBC
Operating cash flow$514.91B
CapEx-$241.60B
Free cash flow$120.46B
Total assets$12.18T
Total liabilities$8.16T
Total equity$4.02T
Cash & equivalents$1.10T
Long-term debt$5.59T
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0$5.33T$190.47B-$88.01B$120.46B
FY-1$5.62T$366.19B$89.37B$114.03B
FY-2$5.02T$148.41B-$133.45B-$371.90B
FY-3$5.17T$273.29B$69.71B$5.09B
FY-4$2.36T$198.90B$720.38B$495.47B
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0$12.18T$4.02T$1.10T
FY-1$12.54T$4.11T$831.82B
FY-2$12.12T$3.84T$825.71B
FY-3$12.00T$3.92T$813.79B
FY-4$8.18T$3.79T$1.72T
PeriodOCFCapExFCFSBC
FY0$514.91B-$241.60B$120.46B
FY-1$557.10B-$385.96B$114.03B
FY-2$325.04B-$624.66B-$371.90B
FY-3$227.91B-$374.12B$5.09B
FY-4$300.78B-$150.45B$495.47B
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0$1.28T
FQ-1$1.23T-$15.30B-$5.94B$65.28B
FQ-2$1.39T$110.19B$14.59B$83.64B
FQ-3$1.32T-$10.98B-$73.16B-$65.55B
FQ-4$1.39T$105.35B-$23.51B$28.07B
FQ-5$1.30T-$25.84B$55.02B$12.31B
FQ-6$1.42T$76.88B$11.73B$43.98B
FQ-7$1.49T$142.80B$24.6M$1.03B
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0$4.13T$1.25T
FQ-1$12.18T$4.02T$1.10T
FQ-2$12.05T$3.97T$816.28B
FQ-3$11.92T$3.89T$865.03B
FQ-4$12.68T$4.10T$803.82B
FQ-5$12.54T$4.11T$831.82B
FQ-6$11.91T$3.87T$592.35B
FQ-7$12.49T$3.96T$720.37B
PeriodOCFCapExFCFSBC
FQ0$174.94B-$50.47B
FQ-1$514.91B-$241.60B$65.28B
FQ-2$153.53B-$203.45B$83.64B
FQ-3$27.01B-$147.86B-$65.55B
FQ-4-$19.78B-$68.75B$28.07B
FQ-5$557.10B-$385.96B$12.31B
FQ-6$175.33B-$260.94B$43.98B
FQ-7$92.50B-$176.25B$1.03B
Valuation
Market price$59900.00
Market cap$1.25T
Enterprise value$5.74T
P/E
Reported non-GAAP P/E
EV/Revenue1.1
EV/Op income30.1
EV/OCF11.2
P/B0.3
P/Tangible book0.3
Tangible book$4.02T
Net cash-$4.49T
Current ratio1.2
Debt/Equity1.4
ROA-0.7%
ROE-2.2%
Cash conversion-5.8%
CapEx/Revenue-4.5%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric000210Activity
Op margin3.6%0.4% medp25 -8.0% · p75 16.0%above median
Net margin-1.7%2.3% medp25 -11.6% · p75 11.8%below median
Gross margin21.1%20.8% medp25 14.9% · p75 24.0%above median
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-4.5%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity139.0%59.0% medp25 54.9% · p75 72.9%top quartile
Observations
IR observations
Mean price target82,000.00 KRW
Median price target82,000.00 KRW
High price target83,000.00 KRW
Low price target81,000.00 KRW
Mean recommendation1.67 (1=strong buy, 5=strong sell)
Strong-buy count1.00
Buy count2.00
Hold count0.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate9,679.50 KRW
Last actual EPS-3,895.00 KRW
Source: analysis-pipeline (hybrid)Generated: 2026-05-17 02:30 UTCJob: 6a41a1c1